相关实验视频
Updated: Jan 11, 2026

09:16
Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
18.5K
功能和蛋白尿症在患有焦点细分性结核硬化症的患者中的患病率,资源利用率和经济影响
Mark E Bensink1, Kamlesh M Thakker, Edgar V Lerma
1HEOR Lead for Sparsentan, Travere Therapeutics, Inc, 3611 Valley Centre Dr, Ste 300, San Diego, CA 92130.
The American journal of managed care
|November 12, 2025
概括
焦点细分性淋巴结核硬化 (FSGS) 患病率在美国增加,特别是在黑人人群中. 较高的蛋白尿和病阶段显著增加了医疗保健成本,突出显示了需要有效治疗的需要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 流行病学 流行病学
- 卫生经济学 卫生经济学
背景情况:
- 焦点细分性淋巴细胞硬化 (FSGS) 是病的重要原因.
- 在FSGS患者中,蛋白尿和功能下降与相当大的经济负担有关.
- 目前美国FSGS的流行病学和经济数据有限.
研究的目的:
- 为了确定FSGS在美国目前的流行率.
- 评估与FSGS相关的经济负担,考虑蛋白尿和慢性病 (CKD) 阶段.
- 为美国人口提供FSGS的最新流行病学见解.
主要方法:
- 一项回顾性队列研究利用了2016年至2020年期间诊断的9899名患者的非识别健康数据.
- 流行率估计标准化为美国人口普查局的人口统计数据.
- 根据蛋白尿水平和CKD阶段,分析了医疗保健资源利用率和成本.
主要成果:
- 据估计,美国每年FSGS的患病率为每百万人口中的212.6.
- 黑人群体中FSGS患病率最高.
- 增加医疗保健利用率和成本与晚期CKD阶段和较高蛋白尿水平相关.
结论:
- 美国的FSGS患病率上升,黑人人口显著增加.
- 晚期CKD和高蛋白尿都是增加医疗保健资源利用率和成本的重要驱动因素.
- 针对减少蛋白尿和减缓功能衰退的干预措施可能会减轻FSGS的经济影响.
更多相关视频
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
187
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
187
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
178
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
178
Chronic Kidney Disease III: Interprofessional Care
331
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
331
Nephrotic Syndrome I : Introduction
484
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
484
Factors Affecting Renal Clearance: Renal Impairment
407
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
407
Acute Kidney Injury III: Clinical Manifestations
791
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
791

